agilon health, inc. (NYSE:AGL – Get Free Report)’s stock price gapped up before the market opened on Thursday following insider buying activity. The stock had previously closed at $1.99, but opened at $2.09. agilon health shares last traded at $2.16, with a volume of 646,589 shares trading hands.
Specifically, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the acquisition, the director now owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here.
Analysts Set New Price Targets
Several analysts recently weighed in on the company. Sanford C. Bernstein started coverage on agilon health in a report on Wednesday. They set a “market perform” rating and a $2.50 price target for the company. Barclays dropped their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Finally, William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, agilon health currently has a consensus rating of “Hold” and a consensus price target of $4.38.
agilon health Stock Performance
The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market cap of $927.05 million, a P/E ratio of -2.39 and a beta of 0.51. The company has a 50 day moving average price of $2.44 and a 200-day moving average price of $4.40.
agilon health (NYSE:AGL – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the firm earned ($0.06) EPS. On average, equities analysts expect that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.
Hedge Funds Weigh In On agilon health
Several institutional investors and hedge funds have recently added to or reduced their stakes in AGL. Arizona State Retirement System increased its stake in shares of agilon health by 2.5% in the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after buying an additional 2,070 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health in the third quarter valued at $28,000. CWM LLC boosted its position in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares during the last quarter. Signaturefd LLC grew its holdings in agilon health by 166.2% during the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after acquiring an additional 7,398 shares during the period. Finally, Wedbush Securities Inc. raised its position in shares of agilon health by 72.6% in the 2nd quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock worth $135,000 after acquiring an additional 8,710 shares in the last quarter.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
- Five stocks we like better than agilon health
- 3 Tickers Leading a Meme Stock Revival
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Insider Trades May Not Tell You What You Think
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Airline Stocks – Top Airline Stocks to Buy Now
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.